User profiles for Leon Caly
 | Leon CalyMedical Scientist, Victorian Infectious Diseases Reference Laboratory Verified email at mh.org.au Cited by 6321 |
[HTML][HTML] The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Although several clinical trials are now underway to test possible therapies, the worldwide
response to the COVID-19 outbreak has been largely limited to monitoring/containment. We …
response to the COVID-19 outbreak has been largely limited to monitoring/containment. We …
Isolation and rapid sharing of the 2019 novel coronavirus (SARS‐CoV‐2) from the first patient diagnosed with COVID‐19 in Australia
Objectives To describe the first isolation and sequencing of SARS ‐CoV‐2 in Australia and
rapid sharing of the isolate. Setting SARS ‐CoV‐2 was isolated from a 58‐year‐old man from …
rapid sharing of the isolate. Setting SARS ‐CoV‐2 was isolated from a 58‐year‐old man from …
[HTML][HTML] Tracking the COVID-19 pandemic in Australia using genomics
Genomic sequencing has significant potential to inform public health management for SARS-CoV-2.
Here we report high-throughput genomics for SARS-CoV-2, sequencing 80% of …
Here we report high-throughput genomics for SARS-CoV-2, sequencing 80% of …
Nuclear trafficking of proteins from RNA viruses: potential target for antivirals?
A key aspect of the infectious cycle of many viruses is the transport of specific viral proteins
into the host cell nucleus to perturb the antiviral response. Examples include a number of …
into the host cell nucleus to perturb the antiviral response. Examples include a number of …
Mpox diagnostics: Review of current and emerging technologies
Mpox is a zoonotic disease caused by monkeypox virus (MPXV) from the Orthopoxvirus
genus. Unprecedented transmission events have led to more than 70 000 cases reported …
genus. Unprecedented transmission events have led to more than 70 000 cases reported …
Nuclear import of the pre-integration complex (PIC): the Achilles heel of HIV?
Current treatments against the Aquired immune deficiency syndrome (AIDS) are reasonably
effective in reducing the amount of human immunodeficiency virus (HIV) present in infected …
effective in reducing the amount of human immunodeficiency virus (HIV) present in infected …
[HTML][HTML] Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
To the Editor—We report the kinetics of immune responses in relation to clinical and virological
features of a patient with mild-to-moderate coronavirus disease 2019 (COVID-19) that …
features of a patient with mild-to-moderate coronavirus disease 2019 (COVID-19) that …
SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse
A group convened and led by the Virus Evolution Working Group of the World Health
Organization reports on its deliberations and announces a naming scheme that will enable …
Organization reports on its deliberations and announces a naming scheme that will enable …
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology
…, Y van der Meer, L Caly… - Journal of General …, 2020 - microbiologyresearch.org
The sudden emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
at the end of 2019 from the Chinese province of Hubei and its subsequent pandemic spread …
at the end of 2019 from the Chinese province of Hubei and its subsequent pandemic spread …
[HTML][HTML] Monkeypox infection presenting as genital rash, Australia, May 2022
Rapid diagnosis and whole genome sequencing confirmed a case of monkeypox in an HIV-positive
individual receiving antiretroviral therapy. The patient had a normal CD4+ T-cell …
individual receiving antiretroviral therapy. The patient had a normal CD4+ T-cell …